Connect® Myeloid Disease Registry

NCT01688011 · clinicaltrials.gov ↗

TERMINATED

Status

2013

Enrollment

INDUSTRY

Sponsor class

Stopped Business objectives have changed

Conditions

Primary Myelofibrosis
Myelodysplastic Syndromes
Leukemia, Myeloid, Acute

Interventions

DRUG: Luspatercept

Sponsor

Celgene